Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: Outcome and associated features

Chest

Volumn 128, Issue 2, 2005, Pages 573-579

  Festic, Emir ^b   Gajic, Ognjen ^a   Limper, Andrew H ^a   Aksamit, Timothy R ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute respiratory failure; ICU; Pneumocystis pneumonia

Indexed keywords

ANTINEOPLASTIC AGENT; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTOTOXIC AGENT; LACTATE DEHYDROGENASE; PENTAMIDINE; PRIMAQUINE;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTUBATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; LUNG INJURY; LUNG LAVAGE; MALE; MEDICAL RECORD; MORTALITY; OUTCOMES RESEARCH; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; TRANSBRONCHIAL BIOPSY; VENTILATOR;

EID: 23744468387     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.2.573     Document Type: Article

References (25)

1. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100:663-671
2. Safrin S. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Semin Respir Infect 1993; 8:96-103
3. HIV/AIDS surveillance supplemental report. Vol. 9. No. 3. 2003 Atlanta, GA: Centers for Disease Control and Prevention
4. Morris A, Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17:73-80
5. Mansharamani NG, Garland R, Delaney D, et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118:704-711
6. Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993; 17(Suppl 2):S416-S422
7. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk. Arch Intern Med 1995; 155:1125-1128
8. Limper AH, Offord KP, Smith TF, et al. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140:1204-1209
9. Thomas CF Jr, Limper AH. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect 1998; 13:289-295
10. Jacobs JA, Dieleman MM, Cornelissen EI, et al. Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia. Acta Cytol 2001; 45:317-326
11. Delclaux C, Zahar JR, Amraoui G, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clin Infect Dis 1999; 29:670-672
12. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998; 113:1215-1224
13. Forrest DM, Djurdjev O, Zala C, et al. Validation of the modified multisystem organ failure score as a predictor of mortality in patients with AIDS-related Pneumocystis carinii pneumonia and respiratory failure. Chest 1998; 114:199-206
14. Forrest DM, Zala C, Djurdjev O, et al. Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia. Arch Intern Med 1999; 159:741-747
15. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996; 71:5-13
16. Haynes RC Jr, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Gilman A, eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 6th ed, New York, NY: Macmillan, 1980; 1466-1496
17. Zimmerman JE, Wagner DP, Draper EA, et al. Evaluation of APACHE III predictions of hospital mortality in an independent database. Crit Care Med 1998; 26:1317-1326
18. Sirio CA, Shepardson LB, Rotondi AJ, et al. Community-wide assessment of intensive care outcomes using a physiologically based prognostic measure. Chest 1999; 115:793-801
19. Cook DA. Performance of APACHE III models in an Australian ICU. Chest 2000; 118:1732-1738
20. Bedos JP, Dumoulin JL, Cachot B, et al. Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med 1999; 27:1109-1115
21. Wachter RM, Luce JM, Safrin S, et al. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA 1995; 273:230-235
22. Murry CE, Schmidt RA. Tissue invasion by Pneumocystis carinii: a possible cause of cavitary pneumonia and pneumothorax. Hum Pathol 1992; 23:1380-1387
23. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
24. Mansharamani NG, Balachandran D, Vernovsky I, et al. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000; 118:712-720
25. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004; 350:2487-2498